Functional and structural alterations as diagnostic imaging markers for depression in de novo Parkinson's disease

被引:4
|
作者
Wang, Hui [1 ]
Xu, Jianxia [2 ]
Yu, Miao [3 ]
Zhou, Gaiyan [3 ]
Ren, Jingru [3 ]
Wang, Yajie [3 ]
Zheng, Huifen [4 ]
Sun, Yu [5 ]
Wu, Jun [6 ]
Liu, Weiguo [3 ]
机构
[1] Nanjing Univ Chinese Med, Lianyungang Affiliated Hosp, Lianyungang Hosp Tradit Chinese Med, Dept Neurol, Lianyungang, Peoples R China
[2] Soochow Univ, Dushu Lake Hosp, Dept Neurol, Suzhou, Peoples R China
[3] Nanjing Med Univ, Affiliated Brain Hosp, Dept Neurol, Nanjing, Peoples R China
[4] Nanjing Med Univ, Geriatr Hosp, Dept Neurol, Nanjing, Peoples R China
[5] Southeast Univ, Sch Biol Sci & Med Engn, Int Lab Children Med Imaging Res, Nanjing, Peoples R China
[6] Nanjing Med Univ, Affiliated Brain Hosp, Dept Clin Lab, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; depression; resting state functional magnetic resonance imaging; structural magnetic resonance imaging; differential diagnosis; RESTING-STATE FMRI; NETWORK CENTRALITY; BRAIN; CONNECTIVITY; AMYGDALA; METAANALYSIS; SYMPTOMS; DISORDER; VOLUME; DYSFUNCTION;
D O I
10.3389/fnins.2023.1101623
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BackgroundDepression in Parkinson's disease (PD) is identified and diagnosed with behavioral observations and neuropsychological measurements. Due to the large overlaps of depression and PD symptoms in clinical manifestations, it is challenging for neurologists to distinguish and diagnose depression in PD (DPD) in the early clinical stage of PD. The advancement in magnetic resonance imaging (MRI) technology provides potential clinical utility in the diagnosis of DPD. This study aimed to explore the alterations of functional and structural MRI in DPD to produce neuroimaging markers in discriminating DPD from non-depressed PD (NDPD) and healthy controls (HC). MethodsWe recruited 20 DPD, 37 NDPD, and 41 HC matched in age, gender, and education years. The patients' diagnosis with PD was de novo. The differences in regional homogeneity (ReHo), voxel-wise degree centrality (DC), cortical thickness, cortical gray matter (GM) volumes, and subcortical GM volumes among these groups were detected, and the relationship between altered indicators and depression was analyzed. Moreover, the receiver operating characteristic (ROC) analysis was performed to assess the diagnostic efficacy of altered indicators for DPD. ResultsCompared to NDPD and HC, DPD showed significantly increased ReHo in left dorsolateral superior frontal gyrus (DSFG) and DC in left inferior temporal gyrus (ITG), and decreased GM volumes in left temporal lobe and right Amygdala. Among these altered indicators, ReHo value in left DSFG and DC values in left ITG and left DSFG were significantly correlated with the severity of depression in PD patients. Comparing DPD and NDPD, the ROC analysis revealed a better area under the curve value for the combination of ReHo value in left DSFG and DC value in left ITG, followed by each independent indicator. However, the difference is not statistically significant. ConclusionThis study demonstrates that both functional and structural impairments are present in DPD. Among them, ReHo value of left DSFG and DC value of left ITG are equally well suited for the diagnosis and differential diagnosis of DPD, with a combination of them being slightly preferable. The multimodal MRI technique represents a promising approach for the classification of subjects with PD.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] The Sequence Effect in De Novo Parkinson's Disease
    Kang, Suk Yun
    Wasaka, Toshiaki
    Shamim, Ejaz A.
    Auh, Sungyoung
    Ueki, Yoshino
    Dang, Nguyet
    Hallet, Marl
    JOURNAL OF MOVEMENT DISORDERS, 2011, 4 (01) : 38 - 40
  • [42] Oculomotor impairments in de novo Parkinson's disease
    Zhou, Meng-Xi
    Wang, Qin
    Lin, Yin
    Xu, Qian
    Wu, Li
    Chen, Ya-Jing
    Jiang, Yu-Han
    He, Qing
    Zhao, Lei
    Dong, You-Rong
    Liu, Jian-Ren
    Chen, Wei
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [43] Decision Making in De Novo Parkinson's Disease
    Poletti, Michele
    Frosini, Daniela
    Lucetti, Claudio
    Del Dotto, Paolo
    Ceravolo, Roberto
    Bonuccelli, Ubaldo
    MOVEMENT DISORDERS, 2010, 25 (10) : 1432 - 1436
  • [44] Association between thyroid dysfunction and severity of depression in de novo patients with Parkinson's disease
    Sarac, I.
    Sarac, H.
    Henigsberg, N.
    Borovecki, F.
    Krakan, L. Bagaric
    Ivek, I.
    Iveta, M.
    Sukobljevic, T.
    Kresic, Z.
    MOVEMENT DISORDERS, 2022, 37 : S510 - S511
  • [45] The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease
    Maillet, Audrey
    Krack, Paul
    Lhommee, Eugenie
    Metereau, Elise
    Klinger, Helene
    Favre, Emilie
    Le Bars, Didier
    Schmitt, Emmanuelle
    Bichon, Amelie
    Pelissier, Pierre
    Fraix, Valerie
    Castrioto, Anna
    Sgambato-Faure, Veronique
    Broussolle, Emmanuel
    Tremblay, Leon
    Thobois, Stephane
    BRAIN, 2016, 139 : 2486 - 2502
  • [46] Structural and Functional Imaging Correlates of Visual Hallucinations in Parkinson’s Disease
    Rohan Bhome
    George Edward Calver Thomas
    Angeliki Zarkali
    Rimona Sharon Weil
    Current Neurology and Neuroscience Reports, 2023, 23 : 287 - 299
  • [47] Neuropsychological Test Performances and Depression in Early-Stage De Novo Parkinson's Disease
    Honsey, Blair N.
    Erickson, Lauren O.
    Wyman-Chick, Kathryn A.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2021, 36 (01) : 112 - 116
  • [48] Structural and Functional Imaging Correlates of Visual Hallucinations in Parkinson's Disease
    Bhome, Rohan
    Thomas, George Edward Calver
    Zarkali, Angeliki
    Weil, Rimona Sharon
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2023, 23 (06) : 287 - 299
  • [49] Longitudinal Progression Markers of Parkinson’s Disease: Current View on Structural Imaging
    Jing Yang
    Roxana G. Burciu
    David E. Vaillancourt
    Current Neurology and Neuroscience Reports, 2018, 18
  • [50] Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease
    Schumacher, Julia
    Kanel, Prabesh
    Dyrba, Martin
    Storch, Alexander
    Bohnen, Nicolaas, I
    Teipel, Stefan
    Grothe, Michel J.
    BRAIN, 2023, 146 (12) : 4964 - 4973